S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
CVE:PRO

Pershimex Resources (PRO) Stock Price, News & Analysis

C$0.03
-0.01 (-14.29%)
(As of 05/8/2023)
Today's Range
C$0.03
C$0.03
50-Day Range
C$0.03
C$0.03
52-Week Range
C$0.02
C$0.04
Volume
15,195 shs
Average Volume
171,615 shs
Market Capitalization
C$4.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
PRO stock logo

About Pershimex Resources Stock (CVE:PRO)

Pershimex Resources Corporation engages in the exploration and evaluation of mineral resources in Canada. The company holds 100% interests in the the Villebon property that include 43 claims covering an area of approximately 18 square kilometers located in the Villebon Township, Abitibi; the Forsan property comprising 27 claims covering an area of approximately 8 square kilometers; and the Courville property that consists of 312 claims covering an area of approximately 151.82 square kilometers located in the Carpentier and Courville townships. It also holds 49% interests in the Malartic property, which comprise 6 blocks of contiguous claims covering an area of approximately 36 square kilometers located near the prolific Cadillac Fault. The company was formerly known as Khalkos Exploration Inc. Pershimex Resources Corporation was incorporated in 2007 and is headquartered in Val-d'Or, Canada.

PRO Stock Price History

PRO Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Best AirPods Pro Accessories for 2024
AirPods Pro
Apple's 2024 OLED iPad Pro: All the Rumors So Far
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Parex Resources price target lowered by C$4.75 at Stifel
Parex Resources price target lowered by C$1 at RBC Capital
13-Inch MacBook Pro
IPMX Provides a Framework for Pro AV
Pro-euthanasia arguments
Best MacBook Pro Deals
iPhone 15 Pro
14- and 16-Inch MacBook Pro
See More Headlines
Receive PRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pershimex Resources and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Industrial Metals & Minerals
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
1,403
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$0.00 per share
Book Value
C$0.06 per share

Miscellaneous

Free Float
N/A
Market Cap
C$4.16 million
Optionable
Not Optionable
Beta
1.12
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Robert Gagnon B.Sc.
    P. Geo., P.Geo., Pres, CEO & Director
  • Mr. Jacques Levesque FCA (Age 76)
    Chief Financial Officer
    Comp: $60k
  • Mr. Jacques Brunelle (Age 61)
    VP of Corp. Devel.
    Comp: $2k
  • Mr. Serge Marc Racine (Age 58)
    Independent Director & Sec.

PRO Stock Analysis - Frequently Asked Questions

How have PRO shares performed in 2024?

Pershimex Resources' stock was trading at C$0.03 at the beginning of the year. Since then, PRO shares have increased by 0.0% and is now trading at C$0.03.
View the best growth stocks for 2024 here
.

What other stocks do shareholders of Pershimex Resources own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pershimex Resources investors own include Co-Diagnostics (CODX), iBio (IBIO), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Ascent Solar Technologies (ASTI), BioRestorative Therapies (BRTX), Digital Ally (DGLY) and FuelCell Energy (FCEL).

How do I buy shares of Pershimex Resources?

Shares of PRO stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:PRO) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners